The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies

There is growing interest in identifying predictive biomarkers for inhibitors of programmed cell death protein 1 receptor (PD-1), programmed death ligand 1 (PD-L1), and cytotoxic T-lymphocyte associated protein 4 (CTLA-4). Given the links between the stool microbiota, anticancer immunosurveillance,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Jun, Chehrazi-Raffle, Alexander, Placencio-Hickok, Veronica, Guan, Michelle, Hendifar, Andrew, Salgia, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423251/
https://www.ncbi.nlm.nih.gov/pubmed/30887236
http://dx.doi.org/10.1186/s40169-019-0225-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423251/
https://www.ncbi.nlm.nih.gov/pubmed/30887236
http://dx.doi.org/10.1186/s40169-019-0225-x

Ejemplares similares